ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸

SXTC // China SXT Pharmaceuticals Inc.

FA <GO> NASDAQ RQD COCKPIT → CIK 0001723980 ↗
Industrials • Diversified Equities
$3.25 ▼ -0.30 (-8.45%)
MKT CAP: $367.7K • VOL: 108.8K
SXTC // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
LINE ITEM (USD / %)
FY 2025
FILED 2026-03-31
FY 2024
FILED 2025-03-31
FY 2023
FILED 2024-03-31
Revenue (Total Sales) $1.1M $1.7M $1.9M
YoY Revenue Growth % — -9.7% —
Gross Profit $248.7K $367.4K —
Gross Margin % 21.9% 21.1% —
Research & Development (R&D) — — —
Operating Income (EBIT) -$7.1M -$2.7M -$2.5M
Operating Margin % -80.0% -80.0% -80.0%
Net Income (GAAP) -$6.2M -$3.3M -$3.1M
EBITDA (Normalized) — -$2.7M —
Diluted EPS ($/sh) — — —
Operating Cash Flow (OCF) -$4.0M -$2.3M -$1.9M
Capital Expenditures (CapEx) — $2.0K —
Free Cash Flow (FCF) -$4.0M -$2.3M -$1.9M
FCF Margin % -80.0% -80.0% -80.0%
Return on Invested Capital (ROIC %) — — —
Cash & Short-Term Equivalents — — —
Total Debt (Short + Long Term) — — —
Total Stockholders' Equity — — —